Mechanism of action for Troxerutin targeting the sialylation-related gene EGLN3 for the treatment of LUAD

Abstract Studies have demonstrated that sialylation changes play a vital part in lung adenocarcinoma (LUAD), yet the specific mechanism is uncertain. Hence, in the present research, we screened sialylation-related biomarkers in LUAD using the bioinformatic strategy, predicted the drugs and performed...

詳細記述

書誌詳細

出版年:	Scientific Reports
主要な著者:	Yanan Wu, Yanlei Ge, Junqing Gan, Ye Jin, Yishuang Cui, Xuan Zheng, Xuemin Yao, Guogui Sun
フォーマット:	論文
言語:	英語
出版事項:	Nature Portfolio 2025-03-01
主題:	Lung adenocarcinoma Sialylation Troxerutin EGLN3
オンライン･アクセス:	https://doi.org/10.1038/s41598-025-92028-2